封面
市場調查報告書
商品編碼
1526194

全球人工心臟瓣膜市場

Prosthetic Heart Valves

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 297 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年全球人工心臟瓣膜市場將達到123億美元

2023年全球人工心臟瓣膜市場預計為74億美元,預計到2030年將達到123億美元,2023-2030年分析期間複合年成長率為7.6%。經導管心臟瓣膜是本報告分析的細分市場之一,預計複合年成長率為 9.8%,到分析期結束時將達到 72 億美元。在分析期間,組織心臟瓣膜段的成長率估計為 7.1%。

美國市場預計30億美元,中國預計複合年成長率9.3%

預計2023年美國人工心臟瓣膜市場規模將達30億美元。中國作為世界第二大經濟體,預計2030年市場規模將達12億美元,2023-2030年分析期間複合年成長率為9.3%。其他值得注意的區域市場包括日本和加拿大,在分析期間預計複合年成長率分別為 7.2% 和 7.1%。在歐洲,德國的複合年成長率預計約為 6.8%。

全球人工心臟瓣膜市場 - 主要趨勢和促進因素總結

人工心臟瓣膜是重要的醫療設備,用於替換受損或患病的心臟瓣膜,以恢復正常的血流並改善患者的預後。這些裝置通常分為兩種類型:機械瓣膜和生物(組織)瓣膜。機械瓣膜由鈦和碳等耐用材料製成,使用壽命長,但需要無限期服用抗凝血劑以防止血栓。由動物組織製成的人工瓣膜,例如牛和豬的心臟瓣膜,耐用性較差,但通常不需要長期抗凝血治療。這兩種類型的人工心臟瓣膜均用於治療主動脈瓣狹窄、二尖瓣瓣膜閉鎖不全和其他可能嚴重影響心血管系統功能和整體健康的心臟瓣膜疾病。

技術進步極大地改變了人造心臟瓣膜的設計和植入程序。經導管主動脈瓣置換術(TAVR) 等創新正在徹底改變該領域,並為傳統心臟直視手術提供微創替代方案。 TAVR 可透過插入小切口(通常在股動脈中)的導管植入人工瓣膜,從而減少恢復時間和併發症,特別是對於高風險患者。此外,3D 超音波心動圖和心臟 MRI 等影像技術的改進增強了術前計劃和瓣膜尺寸調整,以確保更好的貼合和功能。生物材料的進步也有助於下一代瓣膜的開發,這些瓣膜更能模仿自然組織的特性,並且更耐用且具有生物相容性。為了滿足先天性心臟疾病治療的關鍵需求,目前正在研究開發可以隨兒科患者生長和適應的瓣膜。

人工心臟瓣膜市場的成長是由心臟瓣膜疾病盛行率上升、人口老化和醫療技術進步等多種因素所推動的。心臟瓣膜疾病往往與老齡化相關的退化、風濕性心臟疾病以及高血壓和肥胖等文明病有關,增加了瓣膜置換術的需求。世界人口老化進一步加劇了這種需求,因為老年人更容易罹患瓣膜性心臟病。技術的進步,特別是 TAVR 等微創手術技術的進步,正在擴大瓣膜置換術的候選範圍,將那些被認為傳統手術風險過高的患者納入其中。此外,新興地區醫療保健支出的增加和醫療服務的改善正在推動市場擴張。耐用和生物相容性材料的持續開發以及先進影像處理和機器人技術在外科手術中的整合也是主要驅動力。總的來說,這些因素凸顯了人工心臟瓣膜市場的動態成長和創新,凸顯了其在改善心血管健康和患者生活品質方面的重要作用。

受訪企業範例(共28家)

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Medtronic PLC
  • St. Jude Medical, Inc.
  • CryoLife, Inc.
  • LivaNova PLC
  • TTK Healthcare Ltd.
  • Braile Biomedica
  • Lepu Medical Technology(Beijing)Co., Ltd.
  • Colibri Heart Valve LLC
  • JenaValve Technology, Inc.
  • Meril Life Sciences Pvt., Ltd.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP-6753

Global Prosthetic Heart Valves Market to Reach US$12.3 Billion by 2030

The global market for Prosthetic Heart Valves estimated at US$7.4 Billion in the year 2023, is expected to reach US$12.3 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2023-2030. Transcatheter Heart Valves, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$7.2 Billion by the end of the analysis period. Growth in the Tissue Heart Valves segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.0 Billion While China is Forecast to Grow at 9.3% CAGR

The Prosthetic Heart Valves market in the U.S. is estimated at US$3.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 9.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.2% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.8% CAGR.

Global Prosthetic Heart Valves Market - Key Trends & Drivers Summarized

Prosthetic heart valves are critical medical devices used to replace damaged or diseased heart valves, restoring normal blood flow and improving patient outcomes. These devices are typically categorized into two main types: mechanical valves and bioprosthetic (tissue) valves. Mechanical valves, made from durable materials like titanium or carbon, are designed to last a lifetime but require patients to take anticoagulant medication indefinitely to prevent blood clots. Bioprosthetic valves, derived from animal tissues such as bovine or porcine heart valves, are less durable but do not usually necessitate long-term anticoagulation therapy. Both types of prosthetic heart valves are used to treat conditions such as aortic stenosis, mitral regurgitation, and other forms of valvular heart disease, which can severely impact cardiovascular function and overall health.

Technological advancements have significantly transformed the design and implantation procedures of prosthetic heart valves. Innovations such as transcatheter aortic valve replacement (TAVR) have revolutionized the field, providing a minimally invasive alternative to traditional open-heart surgery. TAVR allows for the implantation of a prosthetic valve via a catheter inserted through a small incision, typically in the femoral artery, reducing recovery times and complications, especially in high-risk patients. Additionally, improvements in imaging technologies, like 3D echocardiography and cardiac MRI, have enhanced preoperative planning and valve sizing, ensuring better fit and function. Advances in biomaterials have also contributed to the development of next-generation valves that mimic natural tissue properties more closely, offering improved durability and biocompatibility. Research is ongoing to develop valves that can grow and adapt with pediatric patients, addressing a critical need in congenital heart defect management.

The growth in the prosthetic heart valves market is driven by several factors, including the rising prevalence of valvular heart diseases, an aging population, and advancements in medical technology. The increasing incidence of heart valve disorders, often linked to age-related degeneration, rheumatic heart disease, and lifestyle factors such as hypertension and obesity, has led to greater demand for valve replacement procedures. The aging global population further exacerbates this demand, as older adults are more susceptible to heart valve conditions. Technological advancements, particularly in minimally invasive surgical techniques like TAVR, have expanded the candidate pool for valve replacement, including those previously deemed too high-risk for traditional surgery. Additionally, growing healthcare expenditure and improved access to medical services in developing regions are facilitating market expansion. The continuous development of more durable, biocompatible materials and the integration of advanced imaging and robotic technologies into surgical practice are also key drivers. These factors collectively highlight the dynamic growth and innovation within the prosthetic heart valves market, underscoring its critical role in enhancing cardiovascular health and patient quality of life.

Select Competitors (Total 28 Featured) -

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Medtronic PLC
  • St. Jude Medical, Inc.
  • CryoLife, Inc.
  • LivaNova PLC
  • TTK Healthcare Ltd.
  • Braile Biomedica
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Colibri Heart Valve LLC
  • JenaValve Technology, Inc.
  • Meril Life Sciences Pvt., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Heart Valves: Essential for Blood Flow Control
    • Heart Valve Disorders & Diagnosis
    • Replacement or Repair: Treatment Options for Diseased Heart Valves
    • An Introduction to Prosthetic Heart Valves
    • Types of Prosthetic Heart Valves
    • Prosthetic Heart Valves: Global Market Outlook
    • Growing Prevalence of Valvular Heart Disease: An Opportunity for the Market
    • Transcatheter Heart Valves Segment Continues to Boost Market Prospects
    • Developed Regions Lead, Developing Economies to Spearhead Future Growth
    • Competition
    • Global Heart Valves Market Breakdown by Value Sales (in %) for Leading Players: 2023
    • Transcatheter Aortic Valve Replacement Market Breakdown (in %) by Leading Players for 2023
    • World Brands
    • Recent Market Activity
    • Prosthetic Heart Valves - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Aging Demographics and Resultant Rise in Cardiac Disease Drives Market
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Life Expectancy at Age 60 and 80 Years: (2010-2015), (2020-2025) & (2045-2050)
    • Global Annual Medical Cost of CVD in US$ Billion: 2010, 2015, 2020, 2025 and 2030
    • Sutureless Valves: Potential Substitutes for Conventional Stentless and Stented Biological Valves
    • Growing Interest in Bioprosthetic Valves across Developed Regions
    • Biological Valves: Continuous Improvements Present Growth Opportunities
    • Artificial Mechanical Heart Valves Come of Age
    • Transcatheter Aortic Valve Replacement (TAVR): Poised for High Growth
    • Expanding Indications & New Valves to Boost TAVR Growth
    • Transcatheter Mitral Valve Regurgitation Treatment Faces Hurdles
    • Pediatric Heart Valve Disease: Choosing Between Repair and Replacement
    • An Insight into Mechanical and Biological Valve Prosthesis
    • Mechanical Vs Biological Heart Valves: A Review
    • Noise Emanated by Mechanical Heart Valves May Lead to Insomnia among Recipients
    • Safety Concerns Shifts Focus towards Stentless Valves
    • Tissue Engineered Aortic Valves: The Future
    • Innovations & Advancements in Heart Valve Market to Propel Growth
    • PoliValve: A New Artificial Heart Valve that is both Durable and Biocompatible
    • Using AI to Customize Prosthetic Heart Valves
    • A Novel Copolymer-based Material to Make Sturdier Artificial Heart Valves
    • Expandable Biomimetic Replacement Heart Valve
    • 3D Printed Heart Valves to Improve TAVR Outcomes
    • MitraClip, Caisson Set to Revolutionize the Valve Space
    • Meril Life Sciences Offers Bioprosthetic Valve
    • Polymer Heart Valves: Potential to Improve Outcomes & Reduced Costs
    • Knitting and Weaving Technologies to Develop Heart Valve Fabric
    • Rise in Healthcare Expenditure Bodes Well for the Market
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • Elderly Healthcare Expenditure as a % of GDP for the US, Europe and Japan for 1970, 2010 and 2050
    • Failure of Prosthetic Heart Valve: A Key Concern
    • Symptoms of Malfunctioning Prosthetic Heart Valve
    • Prosthetic Valve Endocarditis (PVE)
    • Prosthetic Valve Thrombosis (PVT)
    • Embolization
    • Structural Breakdown of Bioprosthetic Valves
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Prosthetic Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 3: World 14-Year Perspective for Prosthetic Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2016, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 6: World 14-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Tissue Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 9: World 14-Year Perspective for Tissue Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Mechanical Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Mechanical Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 12: World 14-Year Perspective for Mechanical Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 15: World 14-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 18: World 14-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 21: World 14-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 22: World Prosthetic Heart Valves Market Analysis of Annual Sales in US$ Thousand for Years 2016 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • Market Overview
    • Deaths due to Valvular Heart Disease: Percentage Breakdown by Valve Disease
    • Number of TAVR Procedures in the US for the Years 2012-2023
    • Aging Population Enhances Risk of Heart Valve Disease, Driving Market Growth
    • US Population by Age Group (in %) for 2018, 2030 & 2050
    • North American Aging Population (in Thousands) by Age Group: 1975-2050
    • Minimally Invasive Surgeries for Aortic Stenosis Treatment Gain Popularity
    • Valve Type and Age: Critical Factors Impacting Success of Heart Valve Replacement Surgery
    • Expanded Indications for Transcatheter Heart Valves
    • TABLE 23: USA Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 25: USA 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 28: USA 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 31: Canada 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 34: Canada 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • JAPAN
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • Market Overview
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 37: Japan 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 40: Japan 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • CHINA
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • Market Overview
    • TABLE 41: China Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 43: China 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 46: China 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • EUROPE
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • Market Overview
    • A Peek into the European TAVI Adoption Potential
    • Competition
    • European TAVR Market Breakdown by Leading Competitors (in %) for 2019
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Prosthetic Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 49: Europe 14-Year Perspective for Prosthetic Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2016, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 52: Europe 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 55: Europe 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • FRANCE
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 58: France 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 61: France 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • GERMANY
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 64: Germany 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 67: Germany 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 70: Italy 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 73: Italy 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • UNITED KINGDOM
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 76: UK 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 79: UK 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 82: Spain 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 85: Spain 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 88: Russia 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 91: Russia 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • ASIA-PACIFIC
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Prosthetic Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 14-Year Perspective for Prosthetic Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2016, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • AUSTRALIA
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 109: Australia 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 112: Australia 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • INDIA
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • Heart Valve Market in India: Attractive Opportunities in Store
    • TABLE 113: India Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 115: India 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 118: India 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 121: South Korea 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 124: South Korea 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • LATIN AMERICA
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Geographic Region - Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Prosthetic Heart Valves by Geographic Region - Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 133: Latin America 14-Year Perspective for Prosthetic Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Brazil, Mexico and Rest of Latin America Markets for Years 2016, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 136: Latin America 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 139: Latin America 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 142: Brazil 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 145: Brazil 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 148: Mexico 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 151: Mexico 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 154: Rest of Latin America 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • MIDDLE EAST
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 160: Middle East 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 163: Middle East 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030
  • AFRICA
    • Prosthetic Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 164: Africa Recent Past, Current & Future Analysis for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Africa Historic Review for Prosthetic Heart Valves by Type - Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 166: Africa 14-Year Perspective for Prosthetic Heart Valves by Type - Percentage Breakdown of Value Sales for Transcatheter Heart Valves, Tissue Heart Valves and Mechanical Heart Valves for the Years 2016, 2024 & 2030
    • TABLE 167: Africa Recent Past, Current & Future Analysis for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Africa Historic Review for Prosthetic Heart Valves by End-Use - Hospitals, Ambulatory Surgical Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2016 through 2022 and % CAGR
    • TABLE 169: Africa 14-Year Perspective for Prosthetic Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgical Centers and Other End-Uses for the Years 2016, 2024 & 2030

IV. COMPETITION